Search research articles
Contact Us
Filters
Showing results (141-150 of 706) with videos related to
Page
of 71
Sort By:
The New England Journal of Medicine
|
April 11, 2025
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk. Reply
Gerald F Watts, Robert A Hegele, Nicholas J Leeper
Circulation Research
|
January 2, 2015
Contemporary aspects of the biology and therapeutic regulation of the microsomal triglyceride transfer protein
Amanda J Hooper, John R Burnett, Gerald F Watts
Clinical Genetics
|
December 14, 2019
Widening the spectrum of genetic testing in familial hypercholesterolaemia: Will it translate into better patient and population outcomes?
Michael M Page, Damon A Bell, Gerald F Watts
Expert Review of Clinical Pharmacology
|
April 20, 2019
What's new on therapies for elevated lipoprotein(a)
Natalie C Ward, Carl J Schultz, Gerald F Watts
Drugs
|
December 22, 2004
Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy
Richard J Woodman, Gerard T Chew, Gerald F Watts
The Medical Journal of Australia
|
December 2, 2006
Revisiting the metabolic syndrome
Gerard T Chew, Seng Khee Gan, Gerald F Watts
Heart, Lung & Circulation
|
January 3, 2009
NICE guidance on familial hypercholesterolaemia: all sugar and spice?
Gerald F Watts, Ian Hamilton-Craig, David R Sullivan
International Journal of Cardiology
|
March 16, 2013
A systematic review of economic evaluations of the detection and treatment of familial hypercholesterolemia
Zanfina Ademi, Gerald F Watts, Amanda Juniper, et al.
Clinical Chemistry and Laboratory Medicine
|
July 26, 2003
Identification of lipoproteins of intestinal origin in human atherosclerotic plaque
Sebely Pal, Kishore Semorine, Gerald F Watts, et al.
Current Opinion in Lipidology
|
October 30, 2008
The trials and tribulations of the treatment of nonalcoholic fatty-liver disease
Seng Khee Gan, Leon A Adams, Gerald F Watts
Page
of 71
Search research articles
Search
Showing results (141-150 of 706) with videos related to
Sort By:
Page
of 71
The New England Journal of Medicine
|
April 11, 2025
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk. Reply
Gerald F Watts, Robert A Hegele, Nicholas J Leeper
Circulation Research
|
January 2, 2015
Contemporary aspects of the biology and therapeutic regulation of the microsomal triglyceride transfer protein
Amanda J Hooper, John R Burnett, Gerald F Watts
Clinical Genetics
|
December 14, 2019
Widening the spectrum of genetic testing in familial hypercholesterolaemia: Will it translate into better patient and population outcomes?
Michael M Page, Damon A Bell, Gerald F Watts
Expert Review of Clinical Pharmacology
|
April 20, 2019
What's new on therapies for elevated lipoprotein(a)
Natalie C Ward, Carl J Schultz, Gerald F Watts
Drugs
|
December 22, 2004
Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy
Richard J Woodman, Gerard T Chew, Gerald F Watts
The Medical Journal of Australia
|
December 2, 2006
Revisiting the metabolic syndrome
Gerard T Chew, Seng Khee Gan, Gerald F Watts
Heart, Lung & Circulation
|
January 3, 2009
NICE guidance on familial hypercholesterolaemia: all sugar and spice?
Gerald F Watts, Ian Hamilton-Craig, David R Sullivan
International Journal of Cardiology
|
March 16, 2013
A systematic review of economic evaluations of the detection and treatment of familial hypercholesterolemia
Zanfina Ademi, Gerald F Watts, Amanda Juniper, et al.
Clinical Chemistry and Laboratory Medicine
|
July 26, 2003
Identification of lipoproteins of intestinal origin in human atherosclerotic plaque
Sebely Pal, Kishore Semorine, Gerald F Watts, et al.
Current Opinion in Lipidology
|
October 30, 2008
The trials and tribulations of the treatment of nonalcoholic fatty-liver disease
Seng Khee Gan, Leon A Adams, Gerald F Watts
Page
of 71